Tango Therapeutics Inc (TNGX) — Capital Reinvestment Ratio

Latest as of September 2020: 0.00x

Tango Therapeutics Inc (TNGX) has a Capital Reinvestment Ratio of 0.00x as of September 2020, meaning it reinvests 0% of its operating cash flow ($111.26 Million) in capital expenditures ($132.00K). Check Tango Therapeutics Inc (TNGX) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$111.26 Million

USD

Capital Expenditures

$132.00K

USD

Data as of

Sep 2020

Most recent filing

Tango Therapeutics Inc Capital Reinvestment Ratio (2020–2020)

This chart tracks Tango Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Tango Therapeutics Inc (TNGX) cash conversion ratio.

Annual Capital Reinvestment Ratio for Tango Therapeutics Inc (2020–2020)

Year-by-year Capital Reinvestment Ratio for Tango Therapeutics Inc from 2020 to 2020. See Tango Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2020	0.02x	$70.07 Million	$1.11 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow